|
||
© The Rockefeller University Press,
0021-9525/1997//1293 $5.00
The Journal of Cell Biology, Volume 139, Number 5,
, 1997 1293-1305
Article |
Targeted Deletion of the PEX2 Peroxisome Assembly Gene in Mice Provides a Model for Zellweger Syndrome, a Human Neuronal Migration Disorder
Zellweger syndrome is a peroxisomal biogenesis disorder that results in abnormal neuronal migration in the central nervous system and severe neurologic dysfunction. The pathogenesis of the multiple severe anomalies associated with the disorders of peroxisome biogenesis remains unknown. To study the relationship between lack of peroxisomal function and organ dysfunction, the PEX2 peroxisome assembly gene (formerly peroxisome assembly factor-1) was disrupted by gene targeting.
Homozygous PEX2-deficient mice survive in utero but die several hours after birth. The mutant animals do not feed and are hypoactive and markedly hypotonic. The PEX2-deficient mice lack normal peroxisomes but do assemble empty peroxisome membrane ghosts. They display abnormal peroxisomal biochemical parameters, including accumulations of very long chain fatty acids in plasma and deficient erythrocyte plasmalogens. Abnormal lipid storage is evident in the adrenal cortex, with characteristic lamellar–lipid inclusions. In the central nervous system of newborn mutant mice there is disordered lamination in the cerebral cortex and an increased cell density in the underlying white matter, indicating an abnormality of neuronal migration. These findings demonstrate that mice with a PEX2 gene deletion have a peroxisomal disorder and provide an important model to study the role of peroxisomal function in the pathogenesis of this human disease.
Abbreviations used in this paper: BLBP, brain lipid binding protein; ES, embryonic stem; PBD, peroxisome biogenesis disorder; PC, Purkinje cell; PTS, peroxisomal targeting signal; VLCFA, very long chain fatty acids.
NEURONAL migration disorders are a diverse group of human brain malformations that primarily affect development of the cerebral cortex. Over 25 syndromes with abnormal neuronal migrations have been described and many have been proven to be genetic in origin (Dobyns and Truwit, 1995). Classical studies on the formation of cortical architecture in human brain have revealed four basic steps, including neuronal precursor proliferation in germinal zones, directed migration from germinal zones, assembly of postmigratory cells into discrete layers, and the formation of synaptic connections. The migration of immature cortical neurons on a scaffold of radial glial cells during mid to late gestation is a remarkable feature of cortical formation (Rakic, 1972; Hatten, 1990), providing mechanisms for the disposition of different classes of neurons into specific neuronal layers. While attention has focused on neuron–glia interactions during neuronal locomotion on glial fibers (Zheng et al., 1996), cell organelles such as the peroxisome, which function in cellular metabolism, are also critical to this process.
Zellweger syndrome is a severe, autosomal recessive human neuronal migration disorder. It is a prototype for peroxisome biogenesis disorders (PBDs)1 in which the organelle is not correctly assembled, leading to multiple defects in peroxisome function (Lazarow and Moser, 1994). These infants are readily recognized in the early postnatal period by their characteristic dysmorphic facial features, profound generalized hypotonia, psychomotor delay, and seizures. There is progressive dysfunction of the liver and central nervous system, culminating in death within the first year of life. Morphologic changes are present in multiple organ systems including central nervous system malformations, renal cysts, hepatic fibrosis, joint calcifications, striated adrenocortical cells (Goldfischer et al., 1973), and ocular abnormalities. The clinical spectrum of PBDs also includes the milder disorders neonatal adrenoleukodystrophy (NALD) and infantile Refsum's disease as well as classic rhizomelic chondrodysplasia punctata (RCDP). In these latter disorders, brain malformations are absent or much less prominent than in Zellweger syndrome.
In the Zellweger central nervous system, there is disordered neuronal migration leading to characteristic cytoarchitectonic abnormalities involving the cerebral hemispheres, the cerebellum, and inferior olivary complex (Volpe and Adams, 1972; Evrard et al., 1978). The malformation of the cerebral cortex is most severe and reproducibly results in gyral abnormalities centered around the Sylvian fissure with a stereotypic medial pachygyria and lateral polymicrogyria. These gyral abnormalities reflect a reduced neuronal population in the cortex and large numbers of subcortical heterotopic neurons. These architectonic features, encountered postnatally as well as in pathologic studies on Zellweger fetuses (Powers et al., 1985, 1989), indicate that this malformation results from a developmental disturbance in the migration of neuroblasts to form the cerebral cortical plate throughout much or all of the cytogenetic epoch. In the cerebellum, one finds heterotopic Purkinje cells (PCs) in the white matter, subjacent to intact Purkinje and granule cell laminae, or combinations of abnormally arranged PCs and granule cells (heterotaxias). Dysplastic changes of the principal olivary nucleus and dentate nucleus are seen with a simplification in the normal serpiginous course, laminar discontinuities and condensation of neurons around the periphery of the nuclear islands. In addition, abnormalities develop postnatally in white matter including decreased myelination, reactive astrocytosis, and lipid accumulations in astrocytes.
In the PBDs, there is a block in the posttranslational import of peroxisomal matrix proteins into the organelle, whereas peroxisomal membrane proteins are assembled in the cell into "membrane ghost" structures that appear to be devoid of content (Santos et al., 1987, 1988). The import of matrix proteins bearing the COOH-terminal PTS1 and/or the NH2-terminal PTS2 peroxisomal topogenic targeting signal (Purdue and Lazarow, 1994; Rachubinski and Subramani, 1995) may be differentially affected in these patients (Motley et al., 1994; Slawecki et al., 1995). Biochemical studies have shown a reduced activity of multiple peroxisomal matrix enzymes in the PBDs. In Zellweger syndrome, the peroxisomal dysfunction is characterized by accumulation of very long chain fatty acids (VLCFA), deficient plasmalogen synthesis, and accumulation of pipecolic acid, phytanic acid, and bile acid intermediates (Lazarow and Moser, 1994).
PBDs are genetically heterogeneous disorders that may arise from defects in at least 11 different genes (Moser et al., 1995). Complementation group 10 (group F in Japan) was the first complementation group for which a genetic defect was defined (Shimozawa et al., 1992) and demonstrated to be a mutation in the peroxisome assembly factor-1 gene (now called PEX2; Distel et al., 1996). This zinc-finger– containing, 35-kD peroxisomal integral membrane protein was originally described in a Chinese hamster ovary cell line selected for absence of peroxisomes (Tsukamoto et al., 1990, 1991) and subsequently found to be mutated in another patient with severe Zellweger syndrome (Shimozawa et al., 1993) and two additional Chinese hamster ovary cell lines (Thieringer and Raetz, 1993). The majority of mutations are nonsense mutations leading to premature termination of this protein. The role of Pex2p in peroxisome assembly is not yet understood.
Zellweger syndrome is one of the few human neuronal migration disorders for which genetic defects have been defined. Elucidation of the causal link between absence of peroxisome function and the neuronal migration defect will certainly require the use of animal models, yet no naturally occuring models exist. We have generated a null mutation of the murine PEX2 gene locus and demonstrated that homozygous PEX2-deficient mice show abnormal brain development with a prominent defect in the formation of the cerebral cortex. These mice provide a model system for analyzing the role of peroxisomal function in early phases of development, when cell migration is establishing the form of different brain regions.
| Materials and Methods |
|---|
|
|
|---|
The PCR fragment was used to probe a 129SVJ mouse genomic
FIX II phage library (946309; Stratagene, La Jolla, CA) and a C57BL/6 P6 cerebellum cDNA library in
ZAP (kindly provided by G. Dietz, Rockefeller University, New York, NY). These sequence data are available from Genbank/EMBL/DDBJ under accession number AF031128. The deduced genomic structure of the mouse PEX2 gene is shown in Fig. 1 A.
|
Chimeric mice were generated by injection of four ES cell clones into blastocysts of C57BL/6 donor mice as described (Papaioannou and Johnson, 1993). Highly chimeric males from three of the four ES cell lines were intercrossed with C57BL/6 mice, and agouti offspring were tested for germline transmission by Southern blot analysis. Homozygous PEX2-deficient mice were obtained by interbreeding F1 heterozygotes; F2 offspring were genotyped by PCR analysis (see below).
Southern Blot Analysis
Genomic DNA of ES cell clones was isolated as described (Wurst and Joyner, 1993) and was restriction digested with EcoRI or BglII for the analysis of homologous recombinants. DNA was transferred to Gene-screen Plus (New England Nuclear, Boston, MA) and hybridized according to the manufacturer's protocol. Southern blots were probed with a 0.7-kb BsteII–ClaI PEX2 genomic fragment (5'-probe, probe X) for EcoRI digests or a 0.8-kb BstXI PEX2 genomic fragment (3'-probe, probe Y); both of these probes flank the regions of homology in the targeting vector (Fig. 1 A).
PCR Analysis
PCR of genomic tail DNA of wild-type, heterozygous, and homozygous mice was carried out with a set of three primers: primer a (5'-GGGATAGGGTCAAGATA-TAAAGG-3'), primer b (5'-TAGATGGTGAACCTCCACAGGAAA-3'), and primer c (from neo gene; 5'-ATGCCTGCTTGCCGAATATCATG-3'). A standard 20-µl reaction contains:
0.25 µg DNA and 16 pmol of each primer in reaction buffer containing 10 mM Tris-HCl, pH 8.8, 75 mM KCl, and 1.5 mM MgCl2. After denaturation for 3 min at 94°C and renaturation for 2 min at 60°C, 30 cycles were run with 1.5 min at 72°C, 1 min at 94°C, 1 min at 60°C followed by a final extension for 10 min at 72°C. PCR products were analyzed on 2% agarose gels and yielded the wild-type allele of 400 bp and targeted allele of 800 bp (Fig. 1 C).
Northern Blot Analysis
Total RNA was isolated by the single-step guanidinium thiocyanate-phenol method (Chomczynski and Sacchi, 1987). RNA (20 µg) from brain, liver, and kidney of newborn mice (P0) was heat denatured and fractionated by electrophoresis through a 1.2% formaldehyde–agarose gel and transferred onto a nylon membrane (Gene-screen; New England Nuclear) by capillary blotting. The filter was hybridized according to the manufacturer's instructions with a randomly 32P-labeled 1.25-kb EcoRI PEX2 genomic fragment that contains exon 5 (Fig. 1 A). The final high stringency wash was done in 0.2x SSC, 1% SDS at 65°C. The filter was then stripped of radioactivity and reprobed with a 1.2-kb PstI fragment of GAPDH DNA.
Biochemical Analyses
VLCFA and Plasmalogens.
Blood (
50–100 µl) was collected from newborn mice after decapitation and 10 µl of 7.5% K3EDTA added to prevent clotting. The sample was centrifuged for 10 min at 1,000 g and plasma separated from the pelleted erythrocytes. Samples were stored at –70°C before analysis. Analyses of VLCFA in plasma and erythrocyte plasmalogens were kindly performed for us by Dr. H. Moser and A. Moser (Kennedy Krieger Institute, Baltimore, MD) as described (Bjorkhem et al., 1986; Moser and Moser, 1991).
Liver Fractionation and Catalase Assay.
The liver from newborn mice was collected, weighed, and placed in ice-cold 0.25 M sucrose, 1 mM EDTA, 0.1% ethanol, pH 7.4 (SVE) and processed essentially as described (Lazarow et al., 1991). Briefly, each liver was homogenized in 0.75 ml of SVE (10–15 vol) containing 5 µg/ml of leupeptin, pepstatin, and antipain using a motor-driven Potter-Elvehjem homogenizer and a postnuclear supernatant (PNS) prepared. Two thirds of the PNS was centrifuged at 17,000 g and separated into supernatant and pellet. Catalase (peroxisomes) and N-acetyl-β-glucosaminidase (lysosomes; as an internal control that homogenization was not excessive) were assayed in the postnuclear supernatant, 17,000 g supernatant and pellet as previously described (Lazarow et al., 1988). Protein was measured by BCA reagent (Pierce, Rockford, IL).
Immunohistochemistry
Fibroblasts were isolated from skin of newborn mice. The skin was finely minced, digested in trypsin, and plated in DME, 10% heat inactivated fetal calf serum, 100 mM L-glutamine, and 1x antibiotics. Cells were plated on printed microscopic slides (Cel-Line, Newfield, NJ) with 12-mm diam wells that had previously been coated with 0.01 mg/ml poly-L-lysine and fixed 16–20 h after plating with 4% paraformaldehyde for 20 min at room temperature. Antibodies against bovine catalase and rat liver PxIMPs were a gift from P.B. Lazarow (Mount Sinai Hospital, New York, NY); antibody against peroxisomal 3-ketoacyl-CoA thiloase was a gift from T. Hashimoto (Shinshu University School of Medicine, Matsumoto, Nagano, Japan). The procedure for indirect immunofluorescence was essentially as described (Santos et al., 1988) and used 1% NP40 to permeabilize the cells.
Mice at P0 and embryos at E15 were deeply anesthetized and perfused intracardially with 4% paraformaldehyde in PBS, pH 7.4. The brain was removed and postfixed at 4°C for 24 h in the same fixative, rinsed in PBS, and 100-µm sections prepared on a vibratome (coronal plane for forebrain; saggital plane for cerebellum). Sections were permeabilized and blocked in 1% Tween, 20% normal goat serum in PBS for 90 min. Antibodies were diluted in the above buffer and incubated with the sections overnight at 4°C, including: rabbit anti-GFAP (Dako Corporation, Carpinteria, CA) at 1:200, rabbit anti-BLBP (a gift from N. Heintz, Rockefeller University) at 1:1,000, mouse monoclonal antibody RC2 (Misson et al., 1988) at 1:1, and rabbit anti-calbindin D-28k (SWant, Bellinzona, Switzerland) at 1:1,000. Sections were washed three times for 30 min in PBS. Secondary antibody conjugated to fluorescein (Cappel Research Products, Cochranville, PA) was used at 1:200.
Cells and sections were photographed with a microscope (Axiovert; Zeiss, Inc., Thornwood, NY) fitted with fluorescent illumination plan-neofluor 2.5, 5, 10, 20, 40, and 100x objectives, 1.6x zoom capability, and an Axiophot camera module. For RC2, BLBP, and calbindin D-28k staining, sections were imaged with a confocal scan head (MRC600; Bio Rad, Hercules, CA) and host computer system (PC-AT; IBM, Danbury, CT).
Histology
Brain, spinal cord, and kidney from newborn mice were removed and fixed by immersion in Bouin's fixative for 4 to 20 h at room temperature, followed by rinsing in 70% ethanol. Liver, adrenal, and patella were fixed in 10% formalin. Tissues were embedded in paraffin following standard procedures, sectioned at 7 to 10 µm, and stained with hematoxylin-eosin. Carefully matched coronal sections of brains were photographed with a microscope (Axiovert; Zeiss, Inc.) and print pictures compared to analyze histologic abnormalities in mutant versus control animals.
Whole mount alizarin red/alcian blue staining of newborn mouse skeletons was performed as previously described (Lufkin et al., 1992).
Electron Microscopy
For morphologic studies, liver and adrenal gland from newborn mice were diced in 2.5% glutaraldehyde in 100 mM cacodylate, pH 7.4, and fixed for 3 to 4 h on ice. The tissues were then postfixed in 1% osmium tetroxide in the same buffer, treated with uranyl acetate, dehydrated in ethanol, propylene oxide, and embedded in Epon.
For DAB catalase cytochemistry, liver pieces were fixed in 2% paraformaldehyde containing 2.5% glutaraldehyde in 100 mM cacodylate, pH 7.4, for 3 h. The alkaline 3,3'-diaminobenzidine (DAB) reaction was carried out as previously described (Shio and Lazarow, 1981). After reaction, the slices were washed, postfixed in osmium tetroxide, and processed as above for morphology.
Grids were viewed in an electron microscope (100 CX; Jeol Ltd., Tokyo, Japan) operated at 80 kV.
| Results |
|---|
|
|
|---|
1.8 kb, two other less abundant transcripts are detected (3.9 and 3.25 kb), and all are missing in the homozygous mutant mice. A less abundant transcript of 2.5 kb has been described for human PEX2 (Shimozawa et al., 1992). No homozygous mutant mice were found in 175 surviving offspring at 3 to 4 wk of age. A normal Mendelian ratio of wild-type/heterozygous mice was observed at this age (60 +/+:112 +/–), indicating normal survival of heterozygotes. However, among 331 newborn pups (P0), there were 87 wild-type (+/+), 162 heterozygous (+/–), and 82 homozygous (–/–) mice, the ratio being close to 1:2:1. The majority of PEX2-deficient mice were observed to die shortly after birth (usually <12 h), do not feed, and display a variable in utero growth retardation (mean 29% weight reduction versus littermate controls, range 12–42%; see Fig. 7 A). Although the mutant mice do not feed, one can elicit the normal rhythmic suckling movement of the jaw by mechanical stimulation of the lip (Kutsuwada et al., 1996). Approximately 2% of newborn mutant mice do show small amounts of milk in their stomachs. Rarely, mutant mice have survived up to 1 or 2 d after birth (n = 3). There is no obvious facial or limb dysmorphism (see Fig. 7 A), and seizures have not been observed. The animals respond normally to noxious stimuli. The PEX2-deficient mice move their limbs well but are hypoactive and tend to maintain a "C-shaped," contracted posture. When placed on their paws, the mutants lift their heads poorly and often fall over rapidly. This apparent hypotonia of the mutant mice was evident even in litters of mice obtained very soon after birth and in which none of the animals had fed. In addition, several runted, nonmutant mice have been observed and shown not to display this degree of hypotonia.
|
8–12-fold increase in the c26/22 ratio and 9.5-fold increase in the c26:0 concentration versus control mice (Table I). These elevations are similar to that seen in human peroxisomal biogenesis disorders. The erythrocyte plasmalogen levels (Table II) are severely deficient in the mutant mice, with a 50–60-fold decrease relative to control mice. This plasmalogen deficiency is most similar to that seen in the disorder RCDP, where the plasmalogen deficiency is most severe. Mice heterozygous for the PEX2 gene deletion show no significant difference from control mice in plasma VLCFA and erythrocyte plasmalogens.
|
|
|
|
|
|
To examine the radial glial scaffold, which serves as the guidance substrate for cortical neuronal migration, brains from E15 mice were stained with antibodies against RC2 and brain lipid binding protein (BLBP), both markers for radial glia (Misson et al., 1988; Feng et al., 1994). RC2 and BLBP immunostains showed no obvious abnormality in the radial glial scaffold in brains from homozygous PEX2-deficient mice (Fig. 5 A; BLBP not shown).
|
Inferior Olivary Nucleus, Cerebellum and Spinal Cord
Coronal sections of the hindbrain of P0 mice were examined by serial sections throughout the rostrocaudal extent of the inferior olivary nucleus. In rodents, the principal olivary nucleus is a simple u-shaped structure that lacks the convolutions seen in humans. In the homozygous mutant mice, the component olivary nuclei were normal in position, and there was no evidence of discontinuities in the principal olivary nucleus (data not shown). Preliminary histologic analysis of the principal olivary nucleus in the homozygous PEX2 mutant mice suggests that there may be subtle abnormalities in the shape as well as neuropil of this nucleus; however, these findings remain to be substantiated.
Histologic sections of the cerebellum in P0 mutant mice revealed that the deep cerebellar nuclei and the external granular cell layer were normally formed and folial development was appropriate for the age of the animal. Examination of the P0 cerebellum with antibodies against calbindin-D28k, a PC marker, demonstrated that the vast majority of PCs in mutant mice had reached a normal position within a multilayer beneath the cerebellar surface (Fig. 5 B). These cells had a normal morphology for an early postmigratory PC with numerous thin perisomatic processes (Baptista et al., 1994). In one of three mutant mice examined, a small cluster of PCs was seen slightly beneath the PC multilayer (Fig. 5 B, arrow). These cells had a bipolar morphology with a few long processes, consistent with an earlier embryonic migratory phase (Fig. 5 C), indicating a slight delay in the migration and differentiation of these few cells relative to the majority of PCs. Similar cells were not identified in wild-type mice at P0. Due to the early death of the mutant animals and the immature status of the mouse cerebellum at birth, it is not possible to exclude abnormal positioning of PCs and/or granule cells once the internal granule cell layer has formed (complete by
P14).
The absence of major morphologic changes in the inferior olive or cerebellum is not due to regional differences in expression of the PEX2 gene product. RNA in situ hybridization studies showed a diffuse distribution of the PEX2 transcript in normal mouse brain (data not shown).
Histologic sections of the spinal cord in P0 mutant mice were examined from cervical, thoracic, lumbar, and sacral regions and revealed no obvious abnormality. Lipidosis of neurons, as described by Powers et al. (1987) in Zellweger patients, was not seen.
Liver, Adrenal Gland, Kidney, and Eye
The liver of newborn mutant mice was normal in size and showed no light microscopic abnormalities (data not shown). In electron microscopic analysis of control livers, peroxisomes stain with the cytochemical procedure for catalase (Fig. 6 A) and appear as small round or oval forms with an electron-dense urate oxidase core (6 A, inset), characteristic of rodent peroxisomes. Catalase-reactive particles were not identified in livers from PEX2-deficient mice, and there was no obvious morphologic abnormality in the mitochondria (Fig. 6 B), which reportedly show distortion in shape and matrix condensation in some Zellweger patients (Goldfischer et al., 1973). Immunofluorescence staining of frozen livers from newborn mice with antibodies against catalase also showed diffuse cytoplasmic staining in all of the hepatocytes in the mutant mice, consistent with the cytosolic localization of catalase (data not shown).
|
Light microscopic analysis of the kidneys from newborn mice showed only a slight tubular ectasia in PEX2-deficient mice versus littermate controls (data not shown). There was no evidence of tubular or glomerular cysts in mutant mice. Light microscopic examination of the eyes of newborn mutant mice showed no obvious abnormality (data not shown).
Skeleton
In the Zellweger syndrome, there are characteristic dysmorphic facial features that occur in essentially all patients and stippled calcifications of patellae, femora, and humeri (occur in
69% of patients; Moser et al., 1995). Characteristic facial features include high forehead, hypertelorism, epicanthal folds, hypoplastic supraorbital ridge, and depressed bridge of nose. Many patients also have wide cranial sutures and large fontanelles. In the newborn PEX2-deficient mice, there is no obvious external facial dysmorphism (Fig. 7 A). Examination of the entire mouse skeleton by alcian blue (cartilage) and alizarin red (bone) staining and by radiographic examination showed a normal axial and extremity skeleton and no evidence of calcific stippling in the patella or epiphyses of long bones (data not shown). The bones of the calvarium in the homozygous mutant mice did show a delay in membranous ossification characterized by (a) a reduced amount of bone with a mottled appearance in the medial frontal bones and the interparietal bone (Fig. 7, E–H), and (b) an expanded, oval shape at the medial apposition of the frontal bones (analogous to the anterior fontanelle region in humans) and enlargement of the "posterior fontanelle region" formed by the juncture of the parietal and interparietal bones (see especially Fig. 7, G and H). The majority (70%) of calvaria in control animals are more extensively mineralized and have closely opposed frontal bones (Fig. 7 B). In 19% of control mice, there was a slight opening between the medial frontal bones (Fig. 7 C) but no significant reduction in bone density. However, the calvarial phenotype of the mutant mice correlated with the size of the animal rather than the genotype, as (a) runted wild-type or heterozygous animals showed a similar defect (11% of control animals; weight <1.12 gm; Fig. 7, compare D and F), and (b) larger mutant mice showed a lesser degree of abnormality (Fig. 7, E and F). The remaining facial bones and base of skull bones were normal in appearance and proportionate in size in the mutant mice.
| Discussion |
|---|
|
|
|---|
In Zellweger syndrome, multiple peroxisomal matrix enzymes are deficient due to abnormal assembly of the peroxisomal organelle. Homozygous PEX2-deficient mice have a marked increase in plasma VLCFA and deficient synthesis of plasmalogens in erythrocytes. Fractionation of liver demonstrated that the matrix enzyme catalase was present in the cytosol in mutant mice rather than in its normal particulate location. Morphologic studies on fibroblasts and liver from mutant animals confirmed the absence of normal peroxisomes in these tissues. Hepatocytes in the mutant mice did not contain any normal peroxisomes, indicating absence of mosaicism in the liver, as has been reported in some Zellweger patients as well as in the recently described peroxisomal fatty acyl-coenzyme A oxidase-deficient mice (Fan et al., 1996). In fibroblasts, both the PTS-1 and -2 targeting pathways for import of peroxisomal matrix proteins were disrupted in mutant animals, and peroxisomal membrane proteins were assembled into structures consistent with the "membrane ghosts" described in Zellweger patients (Santos et al., 1988). Motley et al. (1994) and Slawecki et al. (1995) have described heterogeneity in the disruption of the PTS-1 and -2 import pathways amongst fibroblasts from PBD patients in different complementation groups, such that one or both pathways are disrupted. Patients with a PEX2 defect (complementation group 10) were found to have complete disruption of both pathways (Slawecki et al., 1995), as also seen in PEX2 mutant mice.
The central nervous system malformations are the most consistent feature of the Zellweger syndrome with the characteristic array of cerebral cortical, inferior olivary, and cerebellar changes. In PEX2-deficient mice, there is disordered lamination of the cerebral cortex and an increased cell density in the underlying white matter, indicating an abnormality of neuronal migration. Similar to the human condition, the cortex was not uniformly affected; both medial–lateral and anterior–posterior gradients in severity were observed in the mutant mice brains. While the less severe involvement of the ventral–lateral cortex might reflect the greater degree of maturation normally found in the earlier-formed lateral neocortex, the observed anterior–posterior changes do not follow the normal anterior to posterior gradient of cortical maturation (Bayer and Altman, 1991), suggesting an independent mechanism. In the human Zellweger brain, the cortical plate is significantly thinner than in normal brains. However, this was not consistently observed in the PEX2-deficient mice, suggesting that the malformation is less severe in the mouse than in humans. This may reflect (a) the much smaller size of the mouse neocortex, which contains
1,000-fold fewer neurons than the human neocortex (Rakic, 1995), and consequently the much smaller distance that migrating neurons must traverse to reach the cortical plate; (b) a major difference in the duration of the migratory epoch in humans (months) as opposed to mice (days), with cumulative damage accruing over time; and (c) differences in genetic background, with other as yet undefined genes affecting the phenotypic expression of the peroxisomal defect. Immunohistochemical examination of the radial glial scaffold, which serves as the guidance substrate for cortical neuronal migration, did not reveal any obvious structural abnormalities in the mutant mice. However, this does not exclude the presence of ultrastructural or functional abnormalities in the radial glial cells induced by the lack of peroxisomal function.
The inferior olive and cerebellum also show characteristic changes in the Zellweger syndrome. In the PEX2-deficient mice, major morphologic changes were not observed in the inferior olive or dentate nucleus. These nuclei are much simpler, nonlaminated structures in the rodent, reflecting the much smaller size of the lateral cerebellar cortex in rodents versus humans (Altman and Bayer, 1997). Preliminary histologic analysis of the principal olivary nucleus in the PEX2 mutant mice suggests that there may be subtle abnormalities in the shape as well as neuropil of this nucleus; however, these findings remain to be substantiated with more detailed studies of olivary morphology and olivocerebellar connectivity. In the cerebellum of mutant mice, subcortical PC heterotopias were not detected. Although the vast majority of PCs reached the multilayer beneath the cerebellar surface, a small cluster of PCs with a slight delay in migration was detected in one mutant mouse. Thus there may be limited and subtle abnormalities in PC migration in the PEX2-deficient mice. Due to the early death of the mutant animals and the immature status of the mouse cerebellum at birth, it is not possible to evaluate many aspects of cerebellar development. Therefore, we cannot exclude that during the inward migration of external granule cells from the surface of the cerebellum to form the internal granule cell layer that PC heterotopias might result subjacent to the internal granule cell layer as well as the abnormal arrangements of granule cells and PCs that characterize heterotaxias seen in the Zellweger syndrome. In the neurologic mutant mouse reeler, there are extensive subcortical PC heterotopias (more severe than seen in Zellweger syndrome) and shape changes in the principal olivary nucleus (Goffinet et al., 1984), suggesting a relationship between the migratory abnormalities in these cell populations, as has also been suggested in Zellweger syndrome (Evrard et al., 1978). As olivocerebellar topography is established as early as E15 in the mouse (Paradies and Eisenman, 1993), the absence of major olivary changes or subcortical PC heterotopias suggests that malformations that might occur in the PEX2-deficient mice, were they to survive longer, are likely to be mild.
Light and electron microscopy analysis of the adrenal gland in mutant mice demonstrated structures consistent with the lamellar–lipid inclusions described in Zellweger syndrome (Goldfischer et al., 1983). The chemical composition of these inclusions is unknown. They are postulated to be phospholipids containing saturated VLCFA.
Some morphologic features of the Zellweger syndrome were not modeled by the PEX2-deficient mice. As structural changes in the liver, eye, and brain white matter occur during the postnatal period in Zellweger syndrome, one would not expect to see changes in a newborn animal. Renal cysts, seen in
93% of Zellweger patients (Moser et al., 1995) and evident in the fetal period (Powers et al., 1985), were not found in kidneys of newborn mutant mice. The slight tubular ectasia seen in the PEX2 mutant mouse kidneys may reflect early damage and a precursor lesion. Stippled joint calcifications, seen in
69% of Zellweger patients, were also not identified in PEX2-deficient mice. The facial dysmorphism of this syndrome is a central diagnostic feature. However, abnormal facies were not evident in the mutant mice. Zellweger patients are also reported to have enlarged cranial fontanelles. Examination of the mouse skeleton initially suggested the presence of delayed cranial bone mineralization and a larger fontanelle space in the mutant mice. However, this was found to correlate with growth retardation of the animal rather than the mutant genotype. It remains possible that the enlarged fontanelles found in Zellweger patients are also an effect of growth retardation.
The exact cause of death in the PEX2-deficient animals has not been established. Shortly after birth, the mutant mice are normal in color and respiratory pattern, and the heart and lungs are normal in size, suggesting absence of a primary respiratory or circulatory defect. While the inability of the mice to feed certainly contributes to their early demise, the mutant animals die sooner than control animals that have not fed. This suggests toxic accumulation of a metabolic product(s) due to the lack of peroxisomal function, which may be exacerbated by dehydration in these animals.
Establishment of normal cerebral cortical lamination involves several defined steps, including proliferation and early specification of neurons within the ventricular zone, attachment to and migration along radial glial guides, followed by detachment from radial glia and assembly into cortical layers. Examination of migrating neurons, both in vivo (Rakic, 1972) and in vitro (Gregory et al., 1988; Hatten, 1990; Rivas and Hatten, 1995), reveals a characteristic morphology with a thick leading process that wraps around the radial glial fiber, a posterior positioning of the nucleus, and a thin trailing process. Neuronal–glial interactions mediated by the molecule astrotactin (Fishell and Hatten, 1991; Zheng et al., 1996), as well as cell–matrix adhesions (Jessell, 1988; Fishman and Hatten, 1993; Sheppard et al., 1995) and cytoskeletal elements (Rivas and Hatten, 1995), are all believed to be important in the migratory process. It remains to be established how the absence of peroxisomal function in Zellweger syndrome may disrupt any or all of these processes. It has been postulated that elevations of VLCFA and bile acid intermediates may play a toxic role in the Zellweger neuronal migration defect (Powers et al., 1989; Kaufmann et al., 1996). Accumulations of lipid products in migrating neurons and radial glia have been documented in Zellweger fetuses (Powers et al., 1989). In addition, specific cellular processes may be disrupted. Recently, mutations in homologues for the PEX2 gene (Berteaux-Lecellier at al., 1995) and the LIS-1 gene (Xiang et al., 1995), which is abnormal in the Miller-Dieker lissencephaly syndrome (Reiner et al., 1993; Hattori et al., 1994), have been identified in filamentous fungi, and both cause abnormalities in processes involving nuclear migrations within the cell. While Miller-Dieker lissencephaly has a more severe neuronal migration defect than seen in Zellweger syndrome, it shares a common spectrum of affected brain regions, including cerebral cortical gyral abnormalities (pachygyria or agyria), inferior olive dysplasia and heterotopias, and PC heterotopias (Norman et al., 1995). Thus, these diverse gene mutations may affect cellular mechanisms common to nuclear migrations and the translocation of the neuronal cell soma along the radial glial fiber.
The PEX2-deficient mice provide an important animal model for Zellweger syndrome and a major step toward deciphering the cellular mechanisms of this neuronal migration disorder. Zellweger syndrome displays abnormalities in cortical foliation pattern (pachgyria, polymicrogyria) as well as heterotopias that are commonly seen in many human neuronal migration disorders. As cell migration and the formation of neuronal layers occurs prenatally in the mouse, this system can be used to study the role of peroxisomes in these key steps of brain development. Despite the many differences between human and mouse brain development, the presence of a cortical defect in the PEX2-deficient mice indicates a conservation in the mechanisms for neuronal migration. Thus, this mouse model can serve as a system to elucidate the role of peroxisomal function in neuronal migration as well as to unveil general mechanisms for cortical neuronal migration and the establishment of lamination.
While this manuscript was in review, Baes et al. published another mouse model for Zellweger syndrome by targeted deletion of the Pxr1 gene (PEX5) that encodes the PTS-1 receptor (Nat. Genet. 1997. 17:49–57). The phenotype of the Pxr1 –/– mouse is very similar to the PEX2 –/– mouse.
| Acknowledgments |
|---|
This work was supported by National Institutes of Health grants NS-15429 (M.E. Hatten) and the Howard Hughes Medical Institute Physician Postdoctoral Fellowship Program (P.L. Faust).
Submitted: 28 July 1997
Revised: 16 September 1997
Address all correspondence to Phyllis Faust, Department of Pathology, Columbia University, PH Stem 15-124, 630 West 168th Street, New York, NY 10032. Tel.: (212) 305-7339. Fax: (212) 305-4548. E-mail: plf3{at}columbia.edu
| References |
|---|
|
|
|---|
Altman, J., and S.A. Bayer. 1997. Comparative anatomy of the cerebellum: an evolutionary perspective. In Development of The Cerebellar System. CRC Press Inc., New York. 2–25.
Baptista CA, Hatten ME, Blazeski R & Mason CA. Cell-cell interactions influence survival and differentiation of purified purkinje cells in vitro, Neuron, 1994, 12, 243–260.[Medline]
Bayer, S.A., and J. Altman. 1991. Overview of global neurogenetic gradients in the neocortex and limbic cortex. In Neocortical Development. Raven Press, New York. 30–45.
Berteaux-Lecellier V, Picard M, Thompson-Coffe C, Zickler D, Panvier-Adoutte A & Simonet J-M. A nonmammalian homolog of the PAF1 gene (Zellweger syndrome) discovered as a gene involved in caryogamy in the fungus Podospora anserina. , Cell, 1995, 81, 1043–1051.[Medline]
Bjorkhem I, Sisfontes L, Bostrom B, Kase BF & Blomstrand R. Simple diagnosis of the Zellweger syndrome by gas-liquid chromatography of dimethylacetals, J Lipid Res, 1986, 27, 786–791.[Abstract]
Chomczynski P & Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem, 1987, 162, 156–159.[Medline]
Distel B, Erdmann R, Gould SJ, Blobel G, Crane DI, Cregg JM, Dodt G, Fujiki Y, Goodman JM, Just WW et al.. A unified nomenclature for peroxisome biogenesis factors, J Cell Biol, 1996, 135, 1–3.
Dobyns WB & Truwit CL. Lissencephaly and other malformations of cortical development: 1995 update, Neuropediatrics, 1995, 26, 132–147.[Medline]
Evrard P, Caviness VS Jr, Prats-Vinas J & Lyon G. The mechansim of arrest of neuronal migration in the Zellweger malformation: an hypothesis based on cytoarchitectonic analysis, Acta Neuropathol (Berl), 1978, 41, 109–117.[Medline]
Fan C-Y, Pan J, Chu R, Lee D, Kluckman KD, Usuda N, Singh I, Yeldandi AV, Rao MS, Maeda N et al.. Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene, J Biol Chem, 1996, 271, 24698–24710.
Feng L, Hatten ME & Heintz N. Brain lipid-binding protein (BLBP): a novel signaling system in the developing mammalian CNS, Neuron, 1994, 12, 895–908.[Medline]
Fishell G & Hatten ME. Astrotactin provides a receptor system for CNS neuronal migration, Development, 1991, 113, 755–756.[Abstract]
Fishman RB & Hatten ME. Multiple receptor systems promote CNS neural migration, J Neurosci, 1993, 13, 3485–3495.[Abstract]
Goffinet AM, So K-F, Yamamoto M, Edwards M & Caviness VS Jr. Architectonic and hodological organization of the cerebellum in reeler mutant mice, Dev Brain Res, 1984, 16, 263–276.
Goldfischer S, Moore CL, Johnson AB, Spiro AJ, Valsamis MP, Wisniewski HK, Ritch RH, Norton WT, Rapin I & Gartner LM. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome, Science, 1973, 182, 62–64.
Goldfischer S, Powers JM, Johnson AB, Axe S, Brown FR & Moser HW. Striated adrenocortical cells in cerebro-hepato-renal (Zellweger) syndrome, Virchows Arch A Pathol Anat Histopathol, 1983, 401, 355–361.[Medline]
Gregory WA, Edmondson JC, Hatten ME & Mason CA. Cytology and neuron-glial apposition of migrating cerebellar granule cells in vitro. , J Neurosci, 1988, 8, 1728–1738.[Abstract]
Hatten ME. Riding the glial monorail: a common mechanism for glial-guided neuronal migration in different regions of the developing mammalian brain, Trends Neurosci, 1990, 13, 179–184.[Medline]
Hattori M, Adachi H, Tsujimoto M, Arai H & Inoue K. Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetyl-hydrolase, Nature, 1994, 370, 216–218.[Medline]
Jessell TM. Adhesion molecules and the hierarchy of neural development, Neuron, 1988, 1, 3–13.[Medline]
Kaufmann WE, Theda C, Naidu S, Watkins PA, Moser AB & Moser HW. Neuronal migration abnormality in peroxisomal bifunctional enzyme defect, Ann Neurol, 1996, 39, 268–271.[Medline]
Kutsuwada T, Kenji S, Manabe T, Takayama C, Katakura N, Kushiya E, Natsume R, Watanabe M, Inoue Y, Yagi T et al.. Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor e2 subunit mutant mice, Neuron, 1996, 16, 333–344.[Medline]
Lazarow, P.B., and H.W. Moser. 1994. Disorders of peroxisome biogenesis. In The Metabolic and Molecular Basis of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw Hill, New York. 2287– 2324.
Lazarow PB, Small GM, Santos M, Shio H, Moser A, Moser H, Esterman A, Black V & Dancis J. Zellweger syndrome amniocytes: morphological appearance and a simple sedimentation method for prenatal diagnosis, Pediatr Res, 1988, 24, 63–67.[Medline]
Lazarow, P.B., R. Thieringer, G. Cohen, T. Imanaka, and G. Small. 1991. Protein import into peroxisomes in vitro. In Methods in Cell Biology, Vol. 34. A.M. Tartakoff, editor. Academic Press, San Diego. 303–326.
Lufkin T, Mark M, Hart CP, Dolle P, LeMeur M & Chambon P. Homeotic transformation of the occipital bones of the skull by ectopic expression of a homeobox gene, Nature, 1992, 359, 835–841.[Medline]
Misson JP, Edwards MA, Yammamoto M & Caviness VV Jr. Identification of radial glial cells within the developing murine central nervous system: studies based upon a new immunohistochemical marker, Dev Brain Res, 1988, 44, 95–108.[Medline]
Moser, H.W., and A.B. Moser. 1991. Measurements of saturated very long chain fatty acids in plasma. In Techniques in Diagnostic Human Biochemical Genetics. F.E. Hommes, editor. Wiley-Liss, New York. 177–191.
Moser AB, Rasmussen M, Naidu S, Watkins PA, McGuiness M, Hajra AK, Chen G, Raymond G, Liu A, Gordon D et al.. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups, J Pediatr, 1995, 127, 13–22.[Medline]
Motley A, Hettema E, Distel B & Tabak H. Differential protein import deficiencies in human peroxisome assembly disorders, J Cell Biol, 1994, 125, 755–767.
Nagy A, Rossant J, Nagy R, Abramow-Newerly W & Roder J. Derivation of completely cell culture-derived mice from early passage embryonic stem cells, Proc Natl Acad Sci USA, 1993, 90, 8424–8428.
Norman, M.G., B.C. McGillivray, D.K. Kalousek, A. Hill, and K.J. Poskitt. 1995. Neuronal migration disorders and cortical dysplasias. I. Migration disorders. In Congenital Malformations of the Brain: Pathologic, Embryologic, Clinical, Radiologic and Genetic Aspects. Oxford University Press, New York. 223–277.
Papaioannou, V., and R. Johnson. 1993. Production of chimeras and genetically defined offspring from targeted ES cells. In Gene Targeting: A Practical Approach. A.L. Joyner, editor. Oxford University Press, Oxford. 107–146.
Paradies MA & Eisenman LM. Evidence of early topographic organization in the embryonic olivocerebellar projection: a model system for the study of pattern formation processes in the central nervous system, Dev Dyn, 1993, 197, 125–145.[Medline]
Powers JM & Schaumberg HH. The adrenal cortex of adrenoleukodystrophy, Arch Pathol, 1973, 96, 305–310.[Medline]
Powers JM, Moser HW, Moser AB, Upshur JK, Bradford BF, Pai SG, Kohn PH, Frais J & Tiffany C. Fetal cerebrohepatorenal (Zellweger) syndrome: dysmorphic, radiologic, biochemical and pathologic findings in four affected fetuses, Hum Pathol, 1985, 16, 610–620.[Medline]
Powers JM, Tummons RC, Moser AB, Moser HW, Huff DS & Kelley RI. Neuronal lipidosis and neuroaxonal dystrophy in cerebro-hepato-renal (Zellweger) syndrome, Acta Neuropathol (Berl), 1987, 73, 333–343.[Medline]
Powers JM, Tummons RC, Caviness VC Jr, Moser AB & Moser HW. Structural and chemical alterations in the cerebral maldevelopment of fetal cerebro-hepato-renal (Zellweger) syndrome, J Neuropathol Exp Neurol, 1989, 48, 270–289.[Medline]
Purdue PE & Lazarow PB. Peroxisomal biogenesis: multiple pathways of protein import, J Biol Chem, 1994, 269, 30065–30068.
Rachubinski RA & Subramani S. How proteins penetrate peroxisomes, Cell, 1995, 83, 525–528.[Medline]
Rakic P. Mode of cell migration to the superficial layers of fetal monkey neocortex, J Comp Neurol, 1972, 145, 61–84.[Medline]
Rakic P. A small step for the cell, a giant leap for mankind: a hypothesis of neocortical expansion during evolution, Trends Neurosci, 1995, 18, 383–388.[Medline]
Reiner OR, Carrozzo R, Shen Y, Wehner M, Faustinella F, Dobyns WB, Caskey CT & Ledbetter DH. Isolation of Miller-Dieker lissencephaly gene containing G-protein β-subunit-like repeats, Nature, 1993, 364, 717–721.[Medline]
Rivas RJ & Hatten ME. Motility and cytoskeletal organization of migrating cerebellar granule neurons, J Neurosci, 1995, 15, 981–989.[Abstract]
Santos MJ, Imanaka T, Shio H & Lazarow PB. Peroxisomal integral membrane proteins in control and Zellweger fibroblasts, J Biol Chem, 1987, 263, 10502–10509.[Medline]
Santos MJ, Imanaka T, Shio H, Small GM & Lazarow PB. Peroxisomal membrane ghosts in Zellweger syndrome: aberrant organelle assembly, Science, 1988, 239, 1536–1538.
Sheppard AM, Brunstrom JE, Thornton TN, Gerfen RW, Broekelmann TJ, McDonald JA & Pearlman AL. Neuronal production of fibronectin in the cerebral cortex during migration and layer formation is unique to specific cortical domains, Dev Biol, 1995, 172, 504–518.[Medline]
Shio H & Lazarow PB. Relationship between peroxisomes and endoplasmic reticulum investigated by combined catalase and glucose-6-phosphatase cytochemistry, J Histochem Cytochem, 1981, 29, 1263–1272.[Abstract]
Shimozawa N, Tsukamoto T, Suzuki Y, Orii T, Shirayoshi Y, Mori T & Fujiki Y. A human gene responsible for Zellweger syndrome that affects peroxisome assembly, Science, 1992, 255, 1132–1134.
Shimozawa N, Suzuki Y, Orii T, Moser AB, Moser HW & Wanders RJA. Standardization of complementation grouping of peroxisome- deficient disorders and the second Zellweger patient with peroxisome assembly factor-1 (PAF-1) defect, Am J Hum Genet, 1993, 52, 843–844.[Medline]
Slawecki ML, Dodt G, Steinberg S, Moser AB, Moser HW & Gould SJ. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders, J Cell Sci, 1995, 108, 1817–1829.[Abstract]
Thieringer R & Raetz CRH. Peroxisome-deficient Chinese hamster ovary cells with point mutations in peroxisome assembly factor-1, J Biol Chem, 1993, 268, 12631–12636.
Tsukamoto T, Yokota S & Fujiki Y. Isolation and characterization of chinese hamster ovary cell mutants defective in assembly of peroxisomes, J Cell Biol, 1990, 110, 651–660.
Tsukamoto T, Miura S & Fujiki Y. Restoration by a 35K membrane protein of peroxisome assembly in a peroxisome-deficient mammalian cell mutant, Nature, 1991, 350, 77–81.[Medline]
Volpe JJ & Adams RD. Cerebro-hepato-renal syndrome of Zellweger: an inherited disorder of neuronal migration, Acta Neuropathol (Berl), 1972, 20, 175–198.[Medline]
Wurst, W., and A.L. Joyner. 1993. Production of targeted embryonic stem cells. In Gene Targeting: A Practical Approach. A.L. Joyner, editor. Oxford University Press, New York. 33–61.
Wurst W, Auerbach AB & Joyner AL. Multiple developmental defects in Engrailed-1 mutant mice: an early mid-hindbrain deletion and patterning defects in forelimbs and sternum, Development, 1994, 120, 2065–2075.[Abstract]
Xiang X, Osmani AH, Osmani SA, Xin M & Morris NR. NudF, a nuclear migration gene in Aspergillus nidulans, is similar to the human LIS-1 gene required for neuronal migration, Mol Biol Cell, 1995, 6, 297–310.[Abstract]
Zheng C, Heintz H & Hatten ME. CNS gene encoding astrotactin, which supports neuronal migration along glial fibers, Science, 1996, 272, 417–419.[Abstract]
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|